BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

11 articles for N Zorn

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Development of novel benzomorpholine class of diacylglycerol acyltransferase I inhibitors.EBI
Merck Research Laboratories
Discovery of novel quinoline carboxylic acid series as DGAT1 inhibitors.EBI
Merck Research Laboratories
Lead optimization of a pyridine-carboxamide series as DGAT-1 inhibitors.EBI
Merck Research Laboratories
COMPOUND HAVING BIOLOGICAL ACTIVITY SUCH AS ANTIVIRAL ACTIVITYBDB
National Center For Global Health And Medicine
PYRIMIDINONE-CONTAINING 17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 13 INHIBITORSBDB
Enanta Pharmaceuticals
PRMT5 inhibitors and uses therofBDB
Epizyme
Spiroxazolidinone compoundsBDB
Merck Sharp & Dohme
Isoform-specific inhibition of cyclophilins.BDB
Max Planck Research
Competitive inhibition of human poly(A)-specific ribonuclease (PARN) by synthetic fluoro-pyranosyl nucleosides.BDB
University of Thessaly